Life Sciences Vision - new 10 year Life Sciences strategy
posted 7th July 2021
The UK Governments new report, Life Sciences Vision, sets out its 10-year strategy for the sector.
As manufacturing technology develops, and the underpinning materials become more complex and valuable, it is important that Government and the Sector work to attract key elements of the supply chain into the UK. This can ensure that a greater share of the end-to-end manufacturing process is in the UK, capturing the return on the Government's investments in R&D in manufacturing and improving UK health resilience.
The Government and Sector's ambition is to drive a renaissance in UK manufacturing over the next decade.
Business Secretary Kwasi Kwarteng said:
"we're going to build a pro-enterprise environment where our life sciences firms can access the finance to grow, are incentivised to onshore manufacturing, and can commercialise breakthrough products right here in the UK - rather than elsewhere - as we cement the UK's position as a science superpower".
Roland Diggelmann, CEO, Smith+Nephew said:
We welcome this recognition of the importance of the UK's life sciences sector, including our world-class medtech expertise. The UK has a unique healthcare ecosystem where we believe innovation can flourish and the Vision is an important step towards this. As the UK's largest medtech company, Smith+Nephew looks forward to working in partnership with government and colleagues from across the healthcare sector to build on the Vision to benefit the NHS, clinicians, patients and the economy.
More commentary on the report is available on the .GOV website
Dowload the full report by clicking the button below.